Iridex (IRIX) Inventory Turnover Ratio, from second quarter 2026 to second quarter 2025, current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 
Iridex Corp  (NASDAQ: IRIX)
 

Iridex Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Due to inventory build up in the second quarter 2026, Iridex's inventory turnover ratio sequentially decreased to 3.8 in the second quarter 2026, otherwise the ratio remained above the average, as IRIX's markets remain strong.Iridex's average inventory processing period in the Jul 04 2026 quarter, has increased to 96 days, from 93 days, in the Apr 04 2026 quarter.

Within Healthcare sector 101 other companies have achieved higher inventory turnover ratio. While Inventory turnover ratio total ranking has improved so far during the II Quarter 2026, to 995, from total ranking in the first quarter 2026 at 1160.

IRIX Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Iridex Corp Market Share?

What is Inventory Turnover Ratio?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

IRIX Inventory Turnover Ratio (Jul 04 2026)
II. Quarter		 (Apr 04 2026)
I. Quarter		 (Jan 03 2026)
IV. Quarter		 (Sep 27 2025)
III. Quarter		 (Jun 28 2025)
II. Quarter
Y / Y Inventory Growth 15.61 % -8.06 % -27.18 % -33.28 % -24.17 %
Y / Y Cost of Sales Growth 3.37 % 16.67 % 15.59 % 14.29 % 14.29 %
Inventory Turnover Ratio (TTM) 3.8 3.92 3.7 3.27 2.88
IRIX's Total Ranking # 995 # 1160 # 1211 # 1289 # 1385
Average inventory processing period 96 93 99 112 127
Seq. Inventory Growth 4.58 % 18.38 % 7.89 % -13.44 % -16.83 %
Seq. Cost of Sales Growth 18.14 % -24.3 % 15.59 % 0 % 33.33 %




Inventory Turnover Ratio Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 42
Healthcare Sector # 102
Overall Market # 995

Inventory Turnover Ratio Statistics
High Average Low
3.96 2.71 1.75
(Jan 01 2022)   (Sep 29 2012)



IRIX Company Profile >> Back to IRIX Efficiency Comparisons >> Compare IRIX Inventory Turnover Ratio to its Competitors

Financial Statements
Iridex's Inventories $ 10 Millions Visit IRIX's Balance sheet
Iridex's Cost of Revenues TTM $ 33 Millions Visit IRIX's Income Statement
What are IRIX's Sales? Visit IRIX's Sales by Segment

Other Inventory Turnover Ratios
Iridex's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Medical Equipment & Supplies Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
IRIX's Inventory Turnover Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for IRIX's Competitors
Inventory Turnover Ratio for IRIX's Suppliers
Inventory Turnover Ratio for IRIX's Customers

You may also want to know
IRIX's Sales Growth Rates IRIX's Pe Price to earnings ratio IRIX's Receivables Turnover Ratio IRIX's Stock Quote
IRIX's Net Income Growth Rates IRIX's Ps Price to Sales ratio IRIX's Sales per Employee IRIX's Asset Turnover Ratio
IRIX's Net Margin IRIX's Pb Price to Book ratio IRIX's Financial Strength Ratios IRIX's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Jul 04 2026, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Jul 04 2026 Inventories at quarter ending Jul 04 2026
Polomar Health Services, Inc.  8.80 $ 1.233  Millions$ 0  Millions
Myriad Genetics Inc   8.31 $ 250.700  Millions$ 30  Millions
National Vision Holdings Inc   8.26 $ 841.416  Millions$ 102  Millions
Autolus Therapeutics Plc  8.08 $ 99.009  Millions$ 12  Millions
The Oncology Institute Inc   8.03 $ 160.655  Millions$ 20  Millions
Nutriband Inc   7.92 $ 1.082  Millions$ 0  Millions
Inogen Inc   7.51 $ 196.617  Millions$ 26  Millions
Moderna Inc   7.50 $ 1,707.000  Millions$ 228  Millions
Cardiff Lexington Corporation  7.49 $ 4.042  Millions$ 1  Millions
Adaptive Biotechnologies Corporation  7.26 $ 75.254  Millions$ 10  Millions
Adm Tronics Unlimited Inc   6.05 $ 1.970  Millions$ 0  Millions
Sharps Technology Inc   5.68 $ 2.869  Millions$ 1  Millions
Transmedics Group Inc   5.59 $ 276.120  Millions$ 49  Millions
Opko Health Inc   5.42 $ 348.206  Millions$ 64  Millions
Charles River Laboratories International inc   5.39 $ 1,761.363  Millions$ 327  Millions
Tactile Systems Technology Inc   5.12 $ 81.349  Millions$ 16  Millions
Integer Holdings Corporation  5.03 $ 1,369.168  Millions$ 272  Millions
Harrow Inc   4.93 $ 73.636  Millions$ 15  Millions
Ufp Technologies Inc   4.93 $ 452.046  Millions$ 92  Millions
Veracyte Inc   4.84 $ 102.741  Millions$ 21  Millions
West Pharmaceutical Services Inc   4.72 $ 2,103.100  Millions$ 445  Millions
Henry Schein Inc   4.68 $ 9,342.000  Millions$ 1,997  Millions
Guardant Health Inc   4.53 $ 413.947  Millions$ 91  Millions
Idexx Laboratories Inc  4.44 $ 1,714.440  Millions$ 386  Millions
Adc Therapeutics Sa  4.17 $ 5.806  Millions$ 1  Millions
Scilex Holding Company  4.08 $ 14.867  Millions$ 4  Millions
Medinotec Inc   4.08 $ 4.736  Millions$ 1  Millions
3m Company  4.07 $ 15,258.000  Millions$ 3,754  Millions
Electromed Inc   4.02 $ 14.133  Millions$ 4  Millions
Novocure Limited  4.02 $ 166.921  Millions$ 41  Millions

Date modified: 2026-08-19T20:11:05+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.